The imbalance of Th17 and regulatory T cells in pemphigus patients

European Journal of Dermatology

Volumn 23, Issue 6, 2013, Pages 795-802

  Xu, Ren Chao ^a   Zhu, Hai Qin ^a   Li, Wei Ping ^a   Zhao, Xiao Qing ^a   Yuan, Hui Jie ^a   Zheng, Jie ^a   Pan, Meng ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

Anti Dsg1 or Dsg3 antibody; Pemphigus; Regulatory T cells; Th17 cells

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; DESMOGLEIN 1 ANTIBODY; DESMOGLEIN 3 ANTIBODY; IMMUNOGLOBULIN G; INTERLEUKIN 17 ANTIBODY; TRANSCRIPTION FACTOR FOXP3; AUTOANTIBODY; DESMOGLEIN 1; DESMOGLEIN 3; DSG1 PROTEIN, HUMAN; DSG3 PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; ARTICLE; CD25+ T LYMPHOCYTE; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; DNA METHYLATION; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HISTONE MODIFICATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; PEMPHIGUS; REGULATORY T LYMPHOCYTE; TH17 CELL; BLOOD; CD4 LYMPHOCYTE COUNT; CYTOLOGY; IMMUNOLOGY; MIDDLE AGED; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; CD4 LYMPHOCYTE COUNT; DESMOGLEIN 1; DESMOGLEIN 3; FEMALE; HUMANS; MALE; MIDDLE AGED; PEMPHIGUS; T-LYMPHOCYTES, REGULATORY; TH17 CELLS; YOUNG ADULT;

EID: 84893223750     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2013.2177     Document Type: Article

References (35)

1. Hertl M. Humoral and cellular autoimmunity in autoimmune bullous skin disorders. Int Arch Allergy Immunol 2000; 122: 91-100.
2. Mahoney MG, Wang Z, Rothenberger K, Koch PJ, Amagai M, Stanley JR. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. J Clin Invest 1999; 103: 461-8.
3. Bhol K, Natarajan K, Nagarwalla N, Mohimen A, Aoki V, Ahmed AR. Correlation of peptide specificity and IgG subclass with pathogenic and nonpathogenic autoantibodies in pemphigus vulgaris: a model for autoimmunity. Proc Natl Acad Sci U S A 1995; 92: 5239-43.
4. Rock B, Martins CR, Theofilopoulos AN, et al. The pathogenic effect of IgG4 autoantibodies in endemic pemphigus foliaceus (fogo selvagem). N Engl J Med 1989; 320: 1463-9.
5. David M, Katzenelson V, Hazaz B, Ben-Chetrit A, Sandbank M. Determination of IgG subclasses in patients with pemphigus with active disease and in remission. Arch Dermatol 1989; 125: 787-90.
6. Bettelli E, Korn T, Oukka M, Kuchroo VK. Induction and effector functions of T(H)17 cells. Nature 2008; 453: 1051-7.
7. Nakajima K. Critical role of the interleukin-23/T-helper 17 cell axis in the pathogenesis of psoriasis. J Dermatol 2012; 39: 219-24.
8. Aranami T, Yamamura T. Th17 Cells and autoimmune encephalomyelitis (EAE/MS). Allergol Int 2008; 57: 115-20.
9. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell 2008; 133: 775-87.
10. Lim HW, Hillsamer P, Banham AH, Kim CH. Cutting edge: direct suppression of B cells by CD4+ CD25+ regulatory T cells. J Immunol 2005; 175: 4180-3.
11. Lim HW, Hillsamer P, Kim CH. Regulatory T cells can migrate to follicles upon T cell activation and suppress GC-Th cells and GC-Th cell-driven B cell responses. J Clin Invest 2004; 114: 1640-9.
12. Paust S, Cantor H, Regulatory H. T cells and autoimmune disease. Immunol Rev 2005; 204: 195-207.
13. Liu Y, Teige I, Birnir B, Issazadeh-Navikas S. Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE. Nat Med 2006; 12: 518-25.
14. Tang Q, Henriksen KJ, Bi M, et al. In vitro-expanded antigenspecific regulatory T cells suppress autoimmune diabetes. J Exp Med 2004; 199: 1455-65.
15. Liu MF, Wang CR, Fung LL, Wu CR. Decreased CD4+CD25+ T cells in peripheral blood of patients with systemic lupus erythematosus. Scand J Immunol 2004; 59: 198-202.
16. Sugiyama H, Matsue H, Nagasaka A, et al. CD4+CD25high regulatory T cells are markedly decreased in blood of patients with pemphigus vulgaris. Dermatology 2007; 214: 210-20.
17. Arakawa M, Dainichi T, Yasumoto S, Hashimoto T. Lesional Th17 cells in pemphigus vulgaris and pemphigus foliaceus. J Dermatol Sci 2009; 53: 228-31.
18. Veldman C, Stauber A, Wassmuth R, Uter W, Schuler G, Hertl M. Dichotomy of autoreactive Th1 and Th2 cell responses to desmoglein 3 in patients with pemphigus vulgaris (PV) and healthy carriers of PVassociated HLA class II alleles. J Immunol 2003; 170: 635-42.
19. Pan M, Zhou Y, Li W, Zheng J. Modulation of desmoglein-3-specific T cell response and pathogenic antibody generation in mice. Immunol Lett 2008; 120: 6-13.
20. Zhu H, Chen Y, Zhou Y, Wang Y, Zheng J, Pan M. Cognate Th2-B cell interaction is essential for the autoantibody production in pemphigus vulgaris. J Clin Immunol 2012; 32: 114-23.
21. Satyam A, Khandpur S, Sharma VK, Sharma A. Involvement of T(H)1/T(H)2 cytokines in the pathogenesis of autoimmune skin disease-Pemphigus vulgaris. Immunol Invest 2009; 38: 498-509.
22. Chow S, Rizzo C, Ravitskiy L, Sinha AA. The role of T cells in cutaneous autoimmune disease. Autoimmunity 2005; 38: 303-17.
23. Rizzo C, Fotino M, Zhang Y, Chow S, Spizuoco A, Sinha AA. Direct characterization of human T cells in pemphigus vulgaris reveals elevated autoantigen-specific Th2 activity in association with active disease. Clin Exp Dermatol 2005; 30: 535-40.
24. Giordano CN, Sinha AA. Cytokine networks in Pemphigus vulgaris: An integrated viewpoint. Autoimmunity 2012; 45: 427-39.
25. Chen XD, Chen H, Su WT. Role of Th17 cells in patients with pemphigus vulgaris. Journal of Tongji University 2009; 30: 106-9.
26. Hsu HC, Yang P, Wang J, et al. Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat Immunol 2008; 9: 166-75.
27. Harrington LE, Hatton RD, Mangan PR, et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005; 6: 1123-32.
28. Hickman-Brecks CL, Racz JL, Meyer DM, LaBranche TP, Allen PM. Th17 cells can provide B cell help in autoantibody induced arthritis. J Autoimmun 2011; 36: 65-75.
29. Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441: 235-328.
30. Yokoyama T, Matsuda S, Takae Y, et al. Antigen-independent development of Foxp3+ regulatory T cells suppressing autoantibody production in experimental pemphigus vulgaris. Int Immunol 2011; 23: 365-73.
31. Ngalamika O, Zhang Y, Yin H, Zhao M, Gershwin ME, Lu Q. Epigenetics, autoimmunity and hematologic malignancies: a comprehensive review. J Autoimmun 2012; 39: 451-65.
32. Selmi C, Leung PS, Sherr DH, et al. Mechanisms of environmental influence on human autoimmunity: a National Institute of Environmental Health Sciences expert panel workshop. J Autoimmun 2012; 39: 272-84.
33. Zhao M, Huang W, Zhang Q, et al. Aberrant epigenetic modifications in peripheral blood mononuclear cells from patients with pemphigus vulgaris. Br J Dermatol 2012; 167: 523-31.
34. Green MG, Bystryn JC. Effect of intravenous immunoglobulin therapy on serum levels of IgG1 and IgG4 antidesmoglein 1 and antidesmoglein 3 antibodies in pemphigus vulgaris. Arch Dermatol 2008; 144: 1621-4.
35. Kricheli D, David M, Frusic-Zlotkin M, et al. The distribution of pemphigus vulgaris-IgG subclasses and their reactivity with desmoglein 3 and 1 in pemphigus patients and their first-degree relatives. Br J Dermatol 2000; 143: 337-42.